Industry News

Weibo Announces Results of 2022 Annual General Meeting

BEIJING, June 6, 2022 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media inChina, today announced that the following proposed resolutions submitted for shareholder approval have been adopted at its 2022 annual general meeting of shareh...

2022-06-06 17:00 3689

Central China's Yichang City holds the Qu Yuan's hometown Dragon Boat Culture Festival

YICHANG, China, June 6, 2022 /PRNewswire/ -- "Qu Yuan belongs not only to Yichang City, but also the world and all mankind,"Wang Li, vice governor of centralChina's Hubei Province and top official of Yichang City, said emotionally as he addressed the opening ceremony of the 2022 Qu Yuan's Hometow...

2022-06-06 16:24 3056

"Captain Tsubasa: Dream Team" 5th Anniversary Kicks Off & New Players Wearing the JUVENTUS Official Kit Debut

TOKYO, June 6, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Teamkicked off its special 5th Anniversary with the JUVENTUS OFFICIAL CAMPAIGN: Gifts for All and more in-game campaigns onFriday, June 3....

2022-06-06 15:15 3074

Winmate's new 14"rugged tablet delivers an extensive experience on a big screen for the harshest environments

The Winmate M140TG Rugged Extreme is the most potent 14-inch fully rugged tablet available TAIPEI, June 6, 2022 /PRNewswire/ -- Winmate, a rugged computing industry leader, announced its new M140TG 14-inch extreme rugged tablet designed to provide field users mobility and connectivity needed to ...

2022-06-06 13:35 2941

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...

2022-06-06 12:23 3369

iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day

BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...

2022-06-06 12:20 6818

OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology

TOKYO, June 5, 2022 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has closed Series B2 financing from Asahi Kasei Medical Co., Ltd. OriCiro has advanced its busine...

2022-06-06 10:09 2495

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...

2022-06-06 09:00 2517

Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...

2022-06-06 09:00 2391

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...

2022-06-06 09:00 2613

Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform

SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the  Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...

2022-06-06 07:00 4481

LILYSILK Honors World Environment Day with Sustainable Living Initiatives

LOS ANGELES, June 5, 2022  /PRNewswire/ -- In conjunction with this year's World Environment Day , the world's leading silk brand LILYSILK is celebrating with zero-waste initiatives to champion a sustainable lifestyle, and contribute to a greener, better w...

2022-06-05 22:00 8402

Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements

BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...

2022-06-04 04:30 7129

Dogness (International) Corporation Closes $12 Million Offering

DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...

2022-06-04 01:48 8857

Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge

SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...

2022-06-03 23:45 7942

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022

SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...

2022-06-03 23:00 7138

ASIP Tech selected by Wizz Air for free inflight connectivity

NEW YORK, June 3, 2022 /PRNewswire/ -- AS-IP Tech (USOTC: IPTK) announced today it has signed an agreement with Wizz Air (LSE: WIZZ) to provide connectivity on its fleet of A320 and A321 UK based aircraft. In a world first, Wizz Air will integrate AS-IP Tech's fflya Bluetooth platform into its m...

2022-06-03 22:00 7174

JX Luxventure receives Nomination for the "Best Software Solution Provider" Award

HAIKOU, China, June 3, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a company delivering comprehensive products solutions to global elite families serviced by our business customers with business segments covering menswear, cross-border merchandise and tourism, announ...

2022-06-03 21:36 9456

Sylvox Outdoor TV Big Savings Event in Walmart+ Weekend

LOS ANGELES, June 3, 2022 /PRNewswire/ -- Sylvox is participating the first-everWalmart+ Weekend

2022-06-03 20:04 7166

ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

SAN FRANCISCO, June 3, 2022 /PRNewswire/ -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus ...

2022-06-03 20:00 7753